HEALWELL AI INC (AIDX.CA) Fundamental Analysis & Valuation

TSX:AIDX • CA42249X1006

Current stock price

0.96 CAD
+0.01 (+1.05%)
Last:

This AIDX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AIDX.CA Profitability Analysis

1.1 Basic Checks

  • AIDX had negative earnings in the past year.
  • In the past year AIDX has reported a negative cash flow from operations.
  • AIDX had negative earnings in each of the past 5 years.
  • In the past 5 years AIDX reported 4 times negative operating cash flow.
AIDX.CA Yearly Net Income VS EBIT VS OCF VS FCFAIDX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -47.17%, AIDX is doing worse than 76.92% of the companies in the same industry.
  • AIDX has a Return On Equity of -92.69%. This is in the lower half of the industry: AIDX underperforms 69.23% of its industry peers.
Industry RankSector Rank
ROA -47.17%
ROE -92.69%
ROIC N/A
ROA(3y)-41.98%
ROA(5y)-31.25%
ROE(3y)-156.63%
ROE(5y)-292.43%
ROIC(3y)N/A
ROIC(5y)N/A
AIDX.CA Yearly ROA, ROE, ROICAIDX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

  • Looking at the Gross Margin, with a value of 50.39%, AIDX belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • AIDX's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AIDX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.28%
GM growth 5Y6.15%
AIDX.CA Yearly Profit, Operating, Gross MarginsAIDX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. AIDX.CA Health Analysis

2.1 Basic Checks

  • AIDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AIDX has been increased compared to 1 year ago.
  • AIDX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AIDX has an improved debt to assets ratio.
AIDX.CA Yearly Shares OutstandingAIDX.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AIDX.CA Yearly Total Debt VS Total AssetsAIDX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • AIDX has an Altman-Z score of 1.39. This is a bad value and indicates that AIDX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.39, AIDX is in line with its industry, outperforming 53.85% of the companies in the same industry.
  • AIDX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • AIDX's Debt to Equity ratio of 0.40 is amongst the best of the industry. AIDX outperforms 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACCN/A
WACC7.69%
AIDX.CA Yearly LT Debt VS Equity VS FCFAIDX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • AIDX has a Current Ratio of 0.79. This is a bad value and indicates that AIDX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AIDX's Current ratio of 0.79 is in line compared to the rest of the industry. AIDX outperforms 46.15% of its industry peers.
  • A Quick Ratio of 0.79 indicates that AIDX may have some problems paying its short term obligations.
  • AIDX has a Quick ratio (0.79) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.79
AIDX.CA Yearly Current Assets VS Current LiabilitesAIDX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AIDX.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.02% over the past year.
  • Looking at the last year, AIDX shows a very strong growth in Revenue. The Revenue has grown by 180.90%.
  • The Revenue has been decreasing by -3.38% on average over the past years.
EPS 1Y (TTM)43.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)180.9%
Revenue growth 3Y-6.59%
Revenue growth 5Y-3.38%
Sales Q2Q%120.92%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.28% on average over the next years. This is quite good.
  • Based on estimates for the next years, AIDX will show a very strong growth in Revenue. The Revenue will grow by 48.13% on average per year.
EPS Next Y41.21%
EPS Next 2Y28.01%
EPS Next 3Y19.28%
EPS Next 5YN/A
Revenue Next Year173.97%
Revenue Next 2Y89.64%
Revenue Next 3Y61.76%
Revenue Next 5Y48.13%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AIDX.CA Yearly Revenue VS EstimatesAIDX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
AIDX.CA Yearly EPS VS EstimatesAIDX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. AIDX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AIDX. In the last year negative earnings were reported.
  • Also next year AIDX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIDX.CA Price Earnings VS Forward Price EarningsAIDX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIDX.CA Per share dataAIDX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AIDX's earnings are expected to grow with 19.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.01%
EPS Next 3Y19.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AIDX.CA Dividend Analysis

5.1 Amount

  • AIDX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AIDX.CA Fundamentals: All Metrics, Ratios and Statistics

HEALWELL AI INC

TSX:AIDX (3/17/2026, 7:00:00 PM)

0.96

+0.01 (+1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners0.04%
Inst Owner ChangeN/A
Ins Owners13.46%
Ins Owner ChangeN/A
Market Cap282.36M
Revenue(TTM)100.17M
Net Income(TTM)-59.22M
Analysts82.35
Price Target3.13 (226.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-159.92%
Min EPS beat(2)-315.27%
Max EPS beat(2)-4.58%
EPS beat(4)0
Avg EPS beat(4)-214.49%
Min EPS beat(4)-467.59%
Max EPS beat(4)-4.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.52%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-1.58%
Revenue beat(4)0
Avg Revenue beat(4)-3.65%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.56%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.41%
PT rev (3m)-4.87%
EPS NQ rev (1m)8.32%
EPS NQ rev (3m)-15.79%
EPS NY rev (1m)-5.73%
EPS NY rev (3m)-17.37%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-5.85%
Revenue NY rev (1m)-3.83%
Revenue NY rev (3m)-7.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.82
P/FCF N/A
P/OCF N/A
P/B 4.42
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.34
BVpS0.22
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.17%
ROE -92.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.39%
FCFM N/A
ROA(3y)-41.98%
ROA(5y)-31.25%
ROE(3y)-156.63%
ROE(5y)-292.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.28%
GM growth 5Y6.15%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.22%
Cap/Sales 2.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.79
Altman-Z 1.39
F-Score5
WACC7.69%
ROIC/WACCN/A
Cap/Depr(3y)14.05%
Cap/Depr(5y)20.98%
Cap/Sales(3y)2.16%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y41.21%
EPS Next 2Y28.01%
EPS Next 3Y19.28%
EPS Next 5YN/A
Revenue 1Y (TTM)180.9%
Revenue growth 3Y-6.59%
Revenue growth 5Y-3.38%
Sales Q2Q%120.92%
Revenue Next Year173.97%
Revenue Next 2Y89.64%
Revenue Next 3Y61.76%
Revenue Next 5Y48.13%
EBIT growth 1Y10.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year105.58%
EBIT Next 3Y35.42%
EBIT Next 5Y30.02%
FCF growth 1Y-286.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-258.83%
OCF growth 3YN/A
OCF growth 5YN/A

HEALWELL AI INC / AIDX.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEALWELL AI INC (AIDX.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AIDX.CA.


What is the valuation status for AIDX stock?

ChartMill assigns a valuation rating of 0 / 10 to HEALWELL AI INC (AIDX.CA). This can be considered as Overvalued.


Can you provide the profitability details for HEALWELL AI INC?

HEALWELL AI INC (AIDX.CA) has a profitability rating of 1 / 10.


How financially healthy is HEALWELL AI INC?

The financial health rating of HEALWELL AI INC (AIDX.CA) is 2 / 10.


What is the earnings growth outlook for HEALWELL AI INC?

The Earnings per Share (EPS) of HEALWELL AI INC (AIDX.CA) is expected to grow by 41.21% in the next year.